HealthSonix's AquaSonix Therapy Now Available at Two More State of the Art Healthcare Facilities
IRVINE, CA – HealthSonix, Inc. (OTC: HSXI; FRANKFURT: H7S)- MARKET WIRE) -- 11/20/2006 –
HealthSonix today announced the addition of Bloorview Kids Rehab Hospital and Niagara Ina Grafton Gage Village long term care facility to the growing number of its AquaSonix Therapy treatment centers. AquaSonix Therapy is a new therapy program that combines sound pressure waves with low impact exercise in warm water therapy pools, and has been designed to treat patients suffering from arthritis, fibromyalgia and back or muscle pain.
Bloorview Kids Rehab is Canada’s largest children’s rehabilitation hospital. They are known the world over for care, research and education that give children with disabilities the tools to get where they want to go. In 2002, the hospital partnered with the University of Toronto to become Canada’s first teaching hospital in children’s rehabilitation. The Bloorview research institute is home to the country’s top rehab scientists and engineers, whose clinical discoveries and technological inventions benefit children worldwide.
While known as a leading pediatric rehabilitation facility, Bloorview Kids Rehab also provides services to adults with disabilities and special needs. This extension of services enables Bloorview to offer important, assistive technology services to people with disabilities of all ages. Bloorview is Canada's largest children's rehabilitation facility, with an international reputation for innovation in clinical programs, research and education.
Established in 1958, Niagara Ina Grafton Gage Village is a senior’s community, known locally as "the Village." This bright, modern complex is located amid the renowned amenities of the Niagara region, on 15 manicured acres, overlooking the parklands of Walkers Creek valley and Lake Ontario.
“With this new warm water rehabilitation facility we are in a position to effectively serve communities in the entire Niagara peninsula,” stated Dieter Doederlein, Vice President of Corporate Development.
“AquaSonix Therapy is a natural complement to pharmacologic agents," added Dr. David Venturi, HealthSonix’ Medical Director. "Low impact, muscle-strengthening exercises are the cornerstone of the overall management of the patients suffering with the pain of osteoarthritis.”
The AquaSonix Therapy programs are now available not only to the hospital patients and the “village” residents, but also to the local community, referring physicians and rehabilitation specialists in the surrounding areas.
"Our therapies relieve the pain associated with arthritis on their own or in combination with medications. On the average we have seen an additional 50% reduction in pain for patients who are also taking medications for pain and stiffness" added Mr. Doederlein, "We agree with the medical experts: ‘combination therapy’ is the future and the best way to treat patients suffering with chronic diseases such as arthritis."
About HealthSonix Inc.
HealthSonix Inc. (PINKSHEETS: HSXI) (FRANKFURT: H7S) is a publicly traded medical technology company. The Company's core offerings are based on proprietary, patent pending medical technologies that use sound pressure waves to administer sub-sensory micro vibration to the human body. Precisely formatted low frequency sound pressure waves are 80% effective in treating the pain of many diseases, particularly arthritis. All treatments and products are safe, non-invasive, drug free, and have no known side effects.
More information regarding HealthSonix and its products and services can be found on the World Wide Web at: www.HealthSonix.com or by calling the company at 1-877-622-2121.
Note: A number of statements contained in this report are forward-looking statements, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, competitive market conditions, successful integration of acquisitions, the ability to secure additional sources of financing, the ability to reduce operating expenses and other factors not set forth herein. The actual results that the Company may achieve may differ materially from any forward-looking statements due to such risks and uncertainties.
Dieter D. Doederlein
1-877-622-2121
info@healthsonix.com
SOURCE: HealthSonix Inc.
Zurück
Weiter
